News Digest 29.09.2023-02.10.2023
Regulators
Research on a VR breathing simulator has started in Volgograd
In Russia, from October 1, labeling for a number of medical products, biologically active additives (BAA), skin antiseptics and wheelchairs became mandatory. Such changes are regulated by resolutions No. 894 of 05/31/2023, No. 870 of 05/30/2023, No. 886 of 05/31/2023 and No. 885 of 05/31/2023.
At the end of August, the Ministry of Industry and Trade published standard contracts for obtaining labeling codes for wheelchairs, certain types of medical products, dietary supplements and skin antiseptics - disinfectants. They were developed by the department in early June. The documents came into force on September 1.
Market news
Putin instructed Murashko to think through measures within a week to resolve the issue of shortage of glucometers
Vladimir Putin gave Russian Health Minister Mikhail Murashko a week to think through measures to improve the situation with devices for the treatment of diabetes and present him with a report on this topic.
At the same meeting of the head of state with members of the government, Mikhail Murashko said that about 165 drugs for the treatment of type 1 and type 2 diabetes mellitus are registered in Russia, half of them are domestically produced. He also told Putin that six types of domestic test strips for determining blood sugar are now registered.
Other
Research on a VR breathing simulator has started in Volgograd
Scientists have begun conducting research on the world’s first gamified complex for the rehabilitation of pulmonary functions based on a network of medical clinics in Volgograd. The VR simulator is aimed at rehabilitation after ARVI, COVID-19, as well as in general at increasing the potential of human lung functions.
Source: https://nauka.tass.ru/nauka/18884677
Radiologists diagnosed lung diseases more accurately than artificial intelligence
Scientists from Aarhus University Hospital compared the accuracy of diagnosing lung diseases by a radiologist and using available methods based on artificial intelligence (AI) based on X-ray results. The study results were published in the journal Radiology.
The researchers concluded that AI-based methods have moderate to high sensitivity in detecting diseases associated with decreased transparency of lung tissue, pneumothorax and pleural effusion. But the frequency of false positive results when using them is significantly higher. In addition, effectiveness decreased at low volumes and with multiple changes.


